Chapter 19. Wegener's Granulomatosis

  1. Robert P. Lisak MD, FAAN, FRCP Parker Webber Chair Professor Chair Neurologist-in-Chief Chief2,3,
  2. Daniel D. Truong MD, FAAN Head4,
  3. William M. Carroll MBBS, MD, FRACP, FRCP(E) Head5 and
  4. Roongroj Bhidayasiri MD, FRCP Director6,7
  1. Gerard Said MD Professor of Neurology

Published Online: 18 MAY 2010

DOI: 10.1002/9781444317008.ch19

International Neurology: A Clinical Approach

International Neurology: A Clinical Approach

How to Cite

Said, G. (2009) Wegener's Granulomatosis, in International Neurology: A Clinical Approach (eds R. P. Lisak, D. D. Truong, W. M. Carroll and R. Bhidayasiri), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444317008.ch19

Editor Information

  1. 2

    Wayne State University School of Medicine, Detroit, MI, USA

  2. 3

    Detroit Medical Center, Harper University Hospital, Detroit, MI, USA

  3. 4

    The Parkinson and Movement Disorder Institute, Memorial Neuroscience Institute, Orange Coast Memorial Medical Center, Fountain Valley, CA, USA

  4. 5

    Sir Charles Gairdner Hospital, Nedlands, Perth, Australia

  5. 6

    Chulalongkorn Comprehensive Movement Disorders Center, Chulalongkorn University Hospital, Bangkok, Thailand

  6. 7

    University of California at Los Angeles, School of Medicine, Los Angeles, CA, USA

Author Information

  1. Hôpital de la Salpétrière, Paris, France

Publication History

  1. Published Online: 18 MAY 2010
  2. Published Print: 11 SEP 2009

ISBN Information

Print ISBN: 9781405157384

Online ISBN: 9781444317008

SEARCH

Keywords:

  • Wegener's granulomatosis (WG);
  • Churg–Strauss syndrome (CSS);
  • microscopic polyangiitis and polyarteritis nodosa;
  • common manifestations - persistent rhinorrhea;
  • WG - antibody-mediated autoimmune granulomatous vasculitis;
  • ANCAs - antineutrophil cytoplasmic antibodies;
  • ANCAs and WG diagnosis

Summary

This chapter contains sections titled:

  • Further reading